Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676)
10/2013
10/29/2013US8569507 N-(2-oxo-1-phenylpiperidin-3-yl)sulfonamides for the identification of biological and pharmacological activity
10/29/2013US8569506 Modified carbocyanine dyes and their conjugates
10/29/2013US8569502 Quaternary nitrogen heterocyclic compounds for detecting aqueous monosaccharides in physiological fluids
10/29/2013CA2606682C 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline derivatives as medicaments for the treatment of infertility
10/24/2013WO2013158121A1 Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
10/24/2013WO2013157889A1 Use of a novel aminopyridine derivative to prevent or treat cancer
10/24/2013WO2013157528A1 Bicyclic compound
10/24/2013WO2013157018A1 A process for the preparation of the core structure in quinolone and napthyridone class of antibiotics
10/24/2013WO2013121439A3 Garenoxacin mesylate, process for preparation thereof, and crystalline form thereof.
10/24/2013US20130281487 Solid Forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
10/24/2013US20130281415 NEW CYCLOHEXYLAMINE DERIVATIVES HAVING ß2 ADRENERGIC AGONIST AND M3 MUSCARINIC ANTAGONIST ACTIVITIES
10/24/2013US20130281366 Heterocyclic compounds suitable for the treatment of dyslipidemia
10/23/2013EP2651898A1 Novel n- (4- (azetidine - 1 - carbonyl) phenyl) - (hetero - ) arylsulfonamide derivatives as pyruvate kinase m2 (pmk2) modulators
10/23/2013CN103360414A Quinoline rare earth complex, catalyst and polymerization method
10/23/2013CN103360310A Sitafloxacin intermediate, preparation method of sitafloxacin and sitafloxacin pharmaceutical composition
10/23/2013CN103360309A Synthetic method for piperaquine phosphate intermediate 7-chloro-4-(1-piperazino)quinoline
10/23/2013CN103356636A Theramutein调节剂 Theramutein moderator
10/23/2013CN102746223B Separation method of norfloxacin and chloro pipradrol
10/23/2013CN102532015B Solid-phase synthesis method of coumarin and analogue thereof
10/23/2013CN101848895B Combination of anti-angiogenic substance and anti-tumor platinum complex
10/22/2013US8563736 Amide derivatives, process for preparation thereof and use thereof as insecticide
10/22/2013US8563731 Mesylate salt of 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]jamino}-1-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one as agonist of the β2 adrenergic receptor
10/22/2013US8563579 α-7 nicotinic acetylcholine receptor allosteric modulators, their derivatives and uses thereof
10/17/2013WO2013153357A1 Anti-malarial agents
10/17/2013US20130273581 Haptens and immunoreactive agents and use thereof for producing family antibodies and immunoassays for quinolones
10/16/2013EP2650284A1 Heterocyclic derivatives as metabotropic glutamate receptor modulators
10/16/2013CN103351337A Preparation method for coccidiostat decoquinate
10/16/2013CN103351336A Naphthalenecarboxamide derivative as inhibitors of protein kinase and histone deacetylase and preparation method thereof
10/16/2013CN103351335A Synthesis of fluorescence enhanced fluorescent molecular probe for detecting mercapto-containing amino acids, and application of probe
10/16/2013CN102731389B Synthesis method of (R)/(S)-6,6'-benzyloxyl-5,5'-biquinoline
10/16/2013CN102442948B Method for preparing montelukast sodium intermediate
10/16/2013CN102442947B Preparation method of Montelukast Sodium intermediate
10/16/2013CN102174015B Refining method of rebamipide
10/16/2013CN101935301B Modulators of ATP-binding cassette transporters
10/16/2013CN101589026B Method of treatment of glioma brain tumour
10/16/2013CN101516819B Process and intermediates for preparing integrase inhibitors
10/16/2013CN101343420B Unsymmetrical cyanines fluorochrome
10/15/2013US8557993 Crystalline forms of pitavastatin calcium
10/15/2013US8557848 4,5-ring annulated indole derivatives for treating or preventing of HCV and related viral infections
10/15/2013US8557825 Sulfonyl-derivatives as novel inhibitors of histone deacetylase
10/15/2013US8557823 Family of PFKFB3 inhibitors with anti-neoplastic activities
10/15/2013US8557808 Selective beta-glucuronidase inhibitors as a treatment for side effects of camptothecin antineoplastic agents
10/10/2013WO2013149959A1 Salts of 5-[(1r)-2-({2-[4-(2,2-difluoro-2-phenylethoxy)phenyl]ethyl}amino)-1-hydroxyethyl]-8-hydroxyquinolin-2(1h)-one
10/10/2013US20130267703 Compounds useful for treating aids
10/10/2013US20130267559 Quinolinone Derivatives
10/10/2013US20130267536 Substituted methyl amines, serotonin 5-ht6 receptor antagonists, methods for production and use thereof
10/09/2013EP2647627A1 Salts of 5-[(1r)-2-({2-[4-(2,2-difluoro-2-phenylethoxy)phenyl] ethyl}amino)-1-hydroxyethyl]-8-hydroxyquinolin-2(1h)-one.
10/09/2013EP2646417A1 Kat ii inhibitors
10/09/2013EP2646413A1 Alpha,beta-unsaturated imines
10/09/2013CN203229481U Novel cloquintocet-mexyl production device
10/09/2013CN103347859A Synthesis and anticancer activity of aryl and heteroaryl-quinolin derivatives
10/09/2013CN102584698B 2-substutied-3-quinolinic acid ethyl ester compound, preparation method and applications thereof
10/09/2013CN101918365B Inhibitors of human immunodeficiency virus replication
10/08/2013US8552198 Benzimidazole compound crystal
10/08/2013US8552194 Process for preparing quinoline-3-carboxamide derivatives
10/08/2013US8552029 Quinoline derivatives and uses of the same
10/08/2013CA2558389C Process for the synthesis of a cxcr4 antagonist
10/03/2013WO2013148228A1 Pfkfb3 inhibitor and methods of use as an anti-cancer therapeutic
10/03/2013WO2013144180A1 Heteroaryl compounds with cyclic bridging unit for use in the treatment helminth infection
10/03/2013WO2013144179A1 Heteroaryl compounds with a-cyclic bridging unit
10/03/2013WO2013143376A1 Quinoline compounds containing 1,2,4-triazine-3,5-dione and use thereof
10/03/2013WO2013098837A3 A bis-quinaldine compound and a process for preparing the same
10/03/2013US20130261123 Novel Substituted Bicyclic Aromatic Compounds as S-Nitrosoglutathione Reductase Inhibitors
10/02/2013EP2644596A1 Haptens and immunoreactive agents and use thereof for producing family antibodies and immunoassays for quinolones
10/02/2013EP2644587A2 Process and intermediates for preparing integrase inhibitors
10/02/2013EP2642855A1 Intermediate compounds and processes for the preparation of quinoline derivatives such as laquinimod sodium
10/02/2013CN103339111A Bicyclic acetyl-CoA carboxylase inhibitors
10/02/2013CN103333156A Preparation method of 2-substituted arylethenyl-N-methylated quinoline derivative and application of 2-substituted arylethenyl-N-methylated quinoline derivative in preparation of drug for treating Alzheimer disease
10/02/2013CN103333107A Crystals of laquinimod sodium, and process for the manufacture thereof
10/02/2013CN103333106A New method for synthesis of substituted quinoline through reaction of acrylonitrile and substituted phenyl Schiff base
10/02/2013CN103333105A Cadmium specific complexing agent, preparation method thereof and applications thereof
10/02/2013CN101898925B Green synthesis and industrialization method of chloro-substituted heterocyclic ring
10/01/2013US8546575 NIP thiazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydroge-nase-1
10/01/2013US8546427 Tetrahydroquinoline derivatives
10/01/2013US8546416 3-spirocyclic piperidine derivatives as ghrelin receptor agonists
10/01/2013US8546415 Bis-pyridino containing compounds for the use in the treatment of CNS pathologies
10/01/2013US8546392 17Beta-hydroxysteroid dehydrogenase type 1 inhibitors for the treatment of hormone-related diseases
09/2013
09/26/2013WO2013140419A1 A process for synthesis of chiral 3-substituted tetrahydroquinoline derivatives
09/26/2013WO2013139822A1 Novel bisoxime microbiocides
09/26/2013WO2013139712A1 NOVEL POLYMORPHIC CRYSTAL FORMS OF 5-(2-{[6-(2,2-DIFLUORO-2-PHENYLETHOXY)HEXYL]AMINO}-1-(R)-HYDROXYETHYL)-8-HYDROXYQUINOLIN-2(1H)-ONE, HEMINAPADISYLATE AS AGONIST OF THE β2 ADRENERGIC RECEPTOR.
09/26/2013US20130253200 Process and intermediates for preparing integrase inhibitors
09/26/2013US20130252999 2-phenyl-4-quinolones as anticancer agents
09/26/2013US20130252940 c-Met Modulators and Method of Use
09/25/2013EP2641901A1 Novel microbiocides
09/25/2013EP2641900A1 Novel polymorphic Crystal forms of 5-(2-{[6-(2,2-difluoro-2-phenylethoxy) hexyl]amino}-1-(R)-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one, heminapadisylate as agonist of the ß2 adrenergic receptor.
09/25/2013EP2641899A1 Production method for 4-carbonyl oxyquinoline derivative
09/25/2013EP2641897A2 A process for the preparation of 6-(7-((1-aminocyclopropyl)methoxy)-6-methoxyquinolin-4-yloxy)-N-methyl-1-naphthamide and synthetic intermediates thereof
09/25/2013EP2640703A1 Heterocyclic compounds as imaging probes of tau pathology
09/25/2013CN103328449A Novel tetrahydroquinoline derivatives
09/25/2013CN103328448A Haptens and immunoreactive agents and use thereof for producing family antibodies and immunoassays for quinolones
09/25/2013CN103328447A Compounds as c-Met kinase inhibitors
09/25/2013CN103328438A Aryloxyurea compound and pest control agent
09/25/2013CN103320116A Lower alcohol detecting probe, preparation method and application thereof
09/25/2013CN103319404A Nitroxoline derivatives and use of the nitroxoline derivatives as angiogenesis inhibitors
09/25/2013CN103319403A Tumor angiogenesis inhibitor jilintong, preparation method and uses thereof
09/24/2013US8541582 Phenyl bicyclic methyl amine derivatives as sphingosine-1 phosphate receptors modulators
09/24/2013US8541410 Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them
09/24/2013US8541402 Viral polymerase inhibitors
09/24/2013US8541343 Chemical compounds and their use as pesticides
09/19/2013US20130245271 Process for producing 4-carbonyloxyquinoline derivatives
1 ... 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 ... 277